Thromboembolic pulmonary hypertension due to disseminated fibromuscular dysplasia

H Fukuhara1, H Kitayama, T Yokoyama

  • 1Division of Pediatric Cardiology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589, Japan.

Pediatric Cardiology
|September 1, 1996
PubMed

Insights

This study reports two cases of pulmonary hypertension linked to fibromuscular dysplasia (FMD), a rare vascular condition. The findings suggest FMD may cause recurrent blood clots, leading to this serious lung complication.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pulmonary Hypertension Research

Background:

  • Pulmonary hypertension is a severe condition affecting lung arteries.
  • Fibromuscular dysplasia (FMD) is a rare vascular disease characterized by abnormal cell growth in artery walls.
  • The link between FMD and pulmonary hypertension is not well-established.

Observation:

  • Two patients presented with thromboembolic pulmonary hypertension.
  • Both patients exhibited intimal fibroplasia, a hallmark of FMD.
  • Unusual vascular complications were noted, potentially related to disseminated FMD.

Findings:

  • The study observed a novel association between fibromuscular dysplasia and pulmonary hypertension.
  • Intimal fibroplasia in systemic vessels suggests a potential underlying systemic factor.
  • Recurrent pulmonary thromboembolisms, stemming from FMD, are hypothesized as the cause of pulmonary hypertension in these patients.

Implications:

  • These findings highlight a potential new cause of pulmonary hypertension.
  • Early recognition of FMD may be crucial in patients with unexplained thromboembolic events.
  • Further research is needed to elucidate the precise mechanisms linking FMD to pulmonary hypertension and thromboembolism.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...